Today (12 Jan. ’23), MD. Manoon Leechawengwong, a specialist in respiratory diseases Vichaiyut Hospital private facebook post Regarding the world’s new anti-COVID drugs, it is stated that there are only 3 doses of antiviral drugs approved by the US Food and Drug Administration to treat COVID-19, 1 injectable pill is remdesivir, oral pill 2. The parallels are Paxlovid and molnupiravir.
Paxlovid is more effective than molnupiravir. But there are contraindications in case you are taking certain medications. Because there may be drug interactions (Drug Interaction), which may be synergistic or counteracting. affect the treatment results or cause side effects
The whole world is waiting for a new oral antiretroviral drug. Remdesivir works best only when injected into a vein. If it doesn’t work because it is not absorbed through the gastrointestinal tract Chinese scientists have synthesized an oral drug similar to the injection of remdesivir. can be absorbed through the stomach, intestines into the blood stream well A new antiretroviral drug, VV116 (VV116), was conducted in a phase 3 randomized controlled study comparing the antiretroviral drug VV116 with Paxlovid in people infected with the Omicron strain of the COVID-19 virus in the United States. Shanghai Metropolitan Hospital, China, aged 18 years and over with mild to moderate symptoms and is at risk of becoming seriously ill By eating all 5 days published in the New England Journal of Medicine on December 28, 2022, VV116 was found to be effective. Shorten the number of days of illness caused by COVID, reduce the severity, not different from Paxlovid. Less side effects than Paxlovid. less bitter mouth and does not interact with other drugs like Paxlovid
In the near future, a new antiviral drug from China, VV116, will be another oral drug used to treat COVID.
